Topical ganciclovir in the treatment of acute herpetic keratitis

References

• WilhelmusKRThe treatment of herpes simplex virus epithelial keratitisTrans Am Ophthalmol Soc20009850553211190039
   PubMedGoogle Scholar
• HyndiukRGlasserDHerpes simplex keratitisTabbaraKFHyndiukRInfections of the Eye2nd edBoston, MALittle Brown & Co1996
   Google Scholar
• O’BrienWAntiviral agentsTabbaraKHyndiukRInfections of the Eye2nd edBoston, MALittle Brown & Co1996
   Google Scholar
• ElftmanMDHunzekerJTMellingerJCBonneauRHNorburyCCTruckenmillerMEStress-induced glucocorticoids at the earliest stage of herpes simplex virus-1 infection suppress subsequent antiviral immunity, implicating impaired dendritic cell functionJ Immunol201018441867187520089700
   PubMed Web of Science ®Google Scholar
• El HayderiLRatyLFaillaVCaucanasMPauroballyDNikkelsAFSevere herpes simplex virus type-1 infections after dental proceduresMed Oral Patol Oral Cir Bucal612010 [Epub ahead of print]
   Web of Science ®Google Scholar
• DaviesMEBondiJVGrabowskiLSchofieldTLFieldAK2’-nor-2’deoxyguanosine is an effective therapeutic agent for treatment of experimental herpes keratitisAntiviral Res1987721191253495237
   PubMed Web of Science ®Google Scholar
• GordonYJCaponeASheppardJGordonARomanowskiEAraullo-CruzT2’-nor-cGMP, a new cyclic derivative of 2’NDG, inhibits HSV-1 replication in vitro and the mouse keratitis modelCurr Eye Res1987612472533030646
   PubMed Web of Science ®Google Scholar
• ShiotaHNaitoTMimuraYAnti-herpes simplex virus (HSV) effect of 9-(1,3-dihydroxy-2-propoxymethyl) guanine (DHPG) in rabbit corneaCurr Eye Res1987612412453030645
   PubMed Web of Science ®Google Scholar
• CastelaNVermerieNChastFGanciclovir ophthalmic gel in herpes simplex virus rabbit keratitis: Intraocular penetration and efficacyJ Ocul Pharmacol19941024394518083563
   PubMedGoogle Scholar
• ColinJHohHBEastyDLGanciclovir ophthalmic gel (Virgan 0.15%) in the treatment of herpes simplex keratitisCornea19971643933999220235
   PubMed Web of Science ®Google Scholar
• WilhelmusKRTherapeutic interventions for herpes simplex virus epithelial keratitisCochrane Database Syst Rev20071CD00289817253484
   PubMed Web of Science ®Google Scholar
• PouliquenPElenaPPMalecazeFAssessment of the safety and local pharamacokinetics of a 0.15% gel of ganciclovir (Virgan®) in healthy volunteersInvest Ophthalmol Vis Sci199637Suppl 3S313
   Web of Science ®Google Scholar
• ShawMMGürrWKWattsPALittlerEFieldHJGanciclovir and penciclovir, but not acyclovir, induce apoptosis in herpes simplex virus thymidine kinase-transformed baby hamster kidney cellsAntivir Chem Chemother200112317518612959326
   PubMedGoogle Scholar
• EpsteinRJSeedorJADreizenNGPenetrating keratoplasty for herpes simplex keratitis and keratoconus: Allograft rejection and survivalOphthalmology19879489359443309775
   PubMed Web of Science ®Google Scholar
• FickerLAKirknessCMRiceNSSteeleADThe changing management and improved prognosis for corneal grafting in herpes simplex keratitisOphthalmology19899611158715962694048
   PubMed Web of Science ®Google Scholar
• SonkinPLBaratzKHFrothinghamRCoboLMAcyclovir-resistant herpes simplex virus keratouveitis after penetrating keratoplastyOphthalmology19929912180518081336155
   PubMed Web of Science ®Google Scholar
• RapuanoCJCohenEJBradySEArentsenJJLaibsonPRIndications for and outcomes of repeat penetrating keratoplastyAm J Ophthalmol199010966896952346198
   PubMed Web of Science ®Google Scholar
• HohHBHurleyCClaoueCRandomized trial of ganciclovir and acyclovir in the ttreatment of herpes simplex dendritic keratitis: A multicentre studyBr J Ophthalmol19968021401438814744
   PubMed Web of Science ®Google Scholar
• TabbaraKFTreatment of herpetic keratitisOphthalmology20051129164016139674
   PubMed Web of Science ®Google Scholar
• De KeselRJKoppenCIevenMZeyenTPrimary graft failure caused by herpes simplex virus type 1Cornea200120218719011248827
   PubMed Web of Science ®Google Scholar
• TabbaraKFPharmacologic strategies in the prevention and treatment of corneal transplant rejectionInt Ophthalmol200828322323217634865
   PubMedGoogle Scholar
• LairsonDRBegleyCEReynoldsTFWilhelmusKRPrevention of herpes simplex virus eye disease: A cost effectiveness analysisArch Ophthalmol2003121110811212523894
   PubMedGoogle Scholar
• AkovaYAOnatMDaumanSEfficacy of low dose and long term oral acyclovir therapy after penetrating keratoplasty for herpes simplex keratitisOcul Immunol Inflamm199971516010410875
   PubMed Web of Science ®Google Scholar
• BarronBAGeeLHauckWWHerpetic Eye Disease Study. A controlled trial of oral acyclovir for herpes simplex stromal keratitisOphthalmology199410112187118827997323
   PubMed Web of Science ®Google Scholar
• Herpetic Eye Disease Study GroupAcyclovir for the prevention of recurrent herpes simplex virus eye diseaseN Engl J Med199833953003069696640
   PubMed Web of Science ®Google Scholar
• Herpetic Eye Disease Study GroupOral acyclovir for herpes simplex virus eye disease: Effect on prevention of epithelial keratitis and stromal keratitisArch Ophthalmol200011881030103610922194
   PubMedGoogle Scholar
• GoldbergLHKaufmanRHKurtzTOContinuous five-year treatment of patients with frequently recurring genital herpes simplex virus infection with acyclovirJ Med Virol1993Suppl 145508245892
   PubMed Web of Science ®Google Scholar
• MertzGJEronLKaufmanRProlonged continuous versus intermittent oral acyclovir treatment in normal adults with frequently recurring genital herpes simplex virus infectionAm J Med1988852A14193044076
   PubMed Web of Science ®Google Scholar
• FifeKHCrumpackerCSMertzGJHillELBooneGSRecurrence and resistance patterns of herpes simplex virus following cessation of more than or equals to 6 years of chronic suppression with acyclovir. Acyclovir Study GroupJ Infect Dis19941696133813418195614
   PubMed Web of Science ®Google Scholar
• CheeSPJapACytomegalovirus anterior uveitis: outcome of treatmentBr J Ophthalmol2010624 [Epub ahead of print]
   Web of Science ®Google Scholar
• MajumdarSNashedYEPatelKDipeptide monoester ganciclovir prodrugs for treating HSV-1-induced corneal epithelial and stromal keratitis: In vitro and in vivo evaluationsJ Ocul Pharmacol Ther200521646347416386088
   PubMed Web of Science ®Google Scholar
• ColinJGanciclovir ophthalmic gel, 0.15%: A valuable tool for treating ocular herpesClin Ophthalmol20071444145319668521
   PubMedGoogle Scholar
• LabetoulleMThe latest in herpes simplex keratitis therapyJ Fr Ophtalmol2004275547557 [in French]15179314
   PubMed Web of Science ®Google Scholar